Cytek Biosciences, Inc. cotiza a 5.31 USD y tiene una capitalización bursátil de $690M. En los últimos 12 meses ha facturado $207M con un margen de flujo de caja libre del -4.3%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.03 | $-0.10 | $-0.29 |
| Estimado | $0.03 | $-0.02 | $-0.08 | $0.02 |
| Sorpresa | — | -50.0% | -25.0% | -1550.0% |
| Métrica | CTKB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 51.8% | 57.0% | -5.2% |
| Operating Margin | -20.0% | -38.6% | +18.6% |
| Net Margin | -33.0% | -33.6% | +0.5% |
| FCF Margin | -4.3% | -13.9% | +9.5% |
| ROE | -19.5% | -40.4% | +20.9% |
| ROA | -14.4% | -32.0% | +17.6% |
| Current Ratio | 5.04 | 2.84 | +2.20 |
| Debt / Equity | — | 0.28 | — |